Thomas Hc

485 total citations
27 papers, 384 citations indexed

About

Thomas Hc is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Thomas Hc has authored 27 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Hepatology and 3 papers in Genetics. Recurrent topics in Thomas Hc's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (10 papers). Thomas Hc is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (10 papers). Thomas Hc collaborates with scholars based in United Kingdom, Italy and Australia. Thomas Hc's co-authors include M. Sumiya, J.A. Summerfield, Graham R. Foster, S. Sherlock, Sheila Sherlock, S Jain, José‐María Sánchez‐Tapias, James G. Scott, Sami Shousha and Janice Main and has published in prestigious journals such as The Lancet, Genes and Immunity and Antiviral chemistry & chemotherapy.

In The Last Decade

Thomas Hc

25 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Hc United Kingdom 11 236 195 88 53 51 27 384
G Vergani United Kingdom 8 435 1.8× 366 1.9× 173 2.0× 66 1.2× 52 1.0× 11 672
Florian Umlauft Austria 13 249 1.1× 247 1.3× 41 0.5× 29 0.5× 81 1.6× 18 504
M A Gerber United States 13 188 0.8× 214 1.1× 36 0.4× 45 0.8× 66 1.3× 19 498
E Fagan United Kingdom 4 279 1.2× 232 1.2× 47 0.5× 50 0.9× 123 2.4× 7 443
K. Schimpf Germany 12 116 0.5× 112 0.6× 73 0.8× 77 1.5× 61 1.2× 50 606
G Santini Italy 10 186 0.8× 211 1.1× 51 0.6× 99 1.9× 23 0.5× 30 444
Sharon Barrett Ireland 13 279 1.2× 294 1.5× 68 0.8× 26 0.5× 45 0.9× 21 601
Karl‐H. Meyer zum Büschenfelde Germany 9 261 1.1× 250 1.3× 317 3.6× 42 0.8× 56 1.1× 14 676
Stephen Delaney United States 12 163 0.7× 173 0.9× 113 1.3× 31 0.6× 34 0.7× 19 380
Jeannine Yvart France 6 437 1.9× 369 1.9× 22 0.3× 77 1.5× 61 1.2× 10 591

Countries citing papers authored by Thomas Hc

Since Specialization
Citations

This map shows the geographic impact of Thomas Hc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hc more than expected).

Fields of papers citing papers by Thomas Hc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hc. The network helps show where Thomas Hc may publish in the future.

Co-authorship network of co-authors of Thomas Hc

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hc. A scholar is included among the top collaborators of Thomas Hc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hc. Thomas Hc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yee, Leland J., Sylvia Knapp, David Burgner, et al.. (2004). Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection. Genes and Immunity. 5(3). 183–187. 16 indexed citations
2.
Main, Janice, Brendan McCarron, & Thomas Hc. (1998). Treatment of Chronic Viral Hepatitis. Antiviral chemistry & chemotherapy. 9(6). 449–460. 24 indexed citations
3.
Karayiannis, Peter, et al.. (1997). Hepatitis G virus infection. The Lancet. 349(9056). 954–954. 10 indexed citations
4.
Hc, Thomas, et al.. (1996). Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection. The Lancet. 348(9039). 1417–1419. 102 indexed citations
5.
Karayiannis, Peter, et al.. (1993). Immunisation of woodchucks with hepatitis delta antigen expressed by recombinant vaccinia and baculoviruses, controls HDV superinfection.. PubMed. 382. 193–9. 8 indexed citations
6.
Hc, Thomas, et al.. (1992). The host immune response may be responsible for selection of envelope and precore/core variants of HBV.. PubMed. 10. 239–51. 3 indexed citations
7.
Hc, Thomas, et al.. (1990). Chronic hepatitis B.. PubMed. 9. 443–62. 11 indexed citations
8.
Musoke, Richard, et al.. (1986). Cheaper immunisation against hepatitis B.. PubMed. 63(1). 3–12. 2 indexed citations
9.
Fowler, Martin, et al.. (1985). The molecular relationship between HBV infection and hepatoma in Kenya.. PubMed. 62(11). 791–3. 1 indexed citations
10.
Hc, Thomas, I V Weller, A.S. Lok, & Sheila Sherlock. (1983). ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS-B VIRUS-INFECTION. UCL Discovery (University College London). 1 indexed citations
11.
Farci, P, et al.. (1983). Epidemiology and clinical course of delta infection in Britain.. PubMed. 143. 219–23. 5 indexed citations
12.
Hc, Thomas & Weller. (1983). Treatment of chronic hepatitis B virus infection.. PubMed. 10(1). 59–71. 15 indexed citations
13.
Hc, Thomas, et al.. (1983). Approaches to the treatment of chronic hepatitis B viral infection.. PubMed. 143. 379–93. 3 indexed citations
14.
Goodall, Alison H., et al.. (1981). Monoclonal antibodies in a solid-phase radiometric assay for HBsAg.. PubMed. 38(4). 349–54. 14 indexed citations
15.
Scott, James G., Sami Shousha, Thomas Hc, & Sheila Sherlock. (1980). Bile duct carcinoma: a late complication of congenital hepatic fibrosis. Case report and review of literature.. PubMed. 73(2). 113–9. 37 indexed citations
16.
Hc, Thomas, et al.. (1976). Proceedings: Lymphocyte mediated cytotoxicity for Chang liver cells in acute and chronic liver disease.. PubMed. 17(5). 389–389. 6 indexed citations
17.
Hc, Thomas, et al.. (1976). Peripheral blood lymphocyte populations in chronic liver disease.. PubMed. 26(2). 222–7. 57 indexed citations
18.
Elias, Erik, et al.. (1976). Proceedings: C3 metabolism in HBsAg positive and negative chronic active liver disease (CALD).. PubMed. 17(5). 389–389. 6 indexed citations
19.
Hc, Thomas, et al.. (1973). An assessment of the capacity of the liver to remove antigen from the portal circulation in normal and cirrhotic rats.. PubMed. 14(5). 420–420. 1 indexed citations
20.
Hc, Thomas, et al.. (1959). Listeria monocytogenes isolated from patient with congenital heart disease.. PubMed. 55(7). 585–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026